Michael Schrag

1.3k total citations
20 papers, 779 citations indexed

About

Michael Schrag is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Michael Schrag has authored 20 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 11 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Michael Schrag's work include Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (8 papers) and Analytical Chemistry and Chromatography (4 papers). Michael Schrag is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (8 papers) and Analytical Chemistry and Chromatography (4 papers). Michael Schrag collaborates with scholars based in United States, China and France. Michael Schrag's co-authors include Larry C. Wienkers, Magang Shou, Bennett Ma, Michael J. Dabrowski, William M. Atkins, William P. Hammond, Elin Rodger, Gurkamal Chatta, David C. Dale and A. David Rodrigues and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Clinical Cancer Research.

In The Last Decade

Michael Schrag

20 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Schrag United States 14 423 270 219 139 97 20 779
Hsia-lien Lin United States 17 467 1.1× 217 0.8× 249 1.1× 107 0.8× 61 0.6× 26 799
William R. Brian United States 13 656 1.6× 382 1.4× 211 1.0× 67 0.5× 70 0.7× 23 1.1k
Ken Grime United Kingdom 18 557 1.3× 404 1.5× 271 1.2× 188 1.4× 96 1.0× 36 1.1k
Hiroshi Komura Japan 17 286 0.7× 273 1.0× 245 1.1× 100 0.7× 71 0.7× 40 817
Tim F. Ryder United States 11 264 0.6× 148 0.5× 196 0.9× 66 0.5× 64 0.7× 20 659
Jackie C. Bloomer United Kingdom 13 268 0.6× 180 0.7× 261 1.2× 54 0.4× 58 0.6× 20 751
Xavier Boulenc France 15 336 0.8× 303 1.1× 198 0.9× 59 0.4× 54 0.6× 19 814
Susan Cole United Kingdom 14 290 0.7× 268 1.0× 276 1.3× 200 1.4× 103 1.1× 28 916
David A. Tess United States 18 365 0.9× 477 1.8× 296 1.4× 146 1.1× 75 0.8× 45 1.1k
Hugues Dolgos Germany 16 392 0.9× 227 0.8× 208 0.9× 186 1.3× 80 0.8× 26 792

Countries citing papers authored by Michael Schrag

Since Specialization
Citations

This map shows the geographic impact of Michael Schrag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Schrag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Schrag more than expected).

Fields of papers citing papers by Michael Schrag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Schrag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Schrag. The network helps show where Michael Schrag may publish in the future.

Co-authorship network of co-authors of Michael Schrag

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Schrag. A scholar is included among the top collaborators of Michael Schrag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Schrag. Michael Schrag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goyal, Lipika, Cynthia A. Sirard, Michael Schrag, et al.. (2020). Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer. Clinical Cancer Research. 26(23). 6158–6167. 46 indexed citations
2.
Frohn, Mike, Victor J. Cee, Brian A. Lanman, et al.. (2011). Novel 5- and 6-subtituted benzothiazoles with improved physicochemical properties: Potent S1P1 agonists with in vivo lymphocyte-depleting activity. Bioorganic & Medicinal Chemistry Letters. 22(1). 628–633. 9 indexed citations
3.
4.
Ma, Shuguang, Raju Subramanian, Xu Yang, Michael Schrag, & Magang Shou. (2008). Structural Characterization of Novel Adenine Dinucleotide Phosphate Conjugates of Imatinib in Incubations with Rat and Human Liver Microsomes. Drug Metabolism and Disposition. 36(12). 2414–2418. 7 indexed citations
5.
Chen, Ning, Roland W. Bürli, Susana Neira, et al.. (2008). Discovery of a potent and selective c-Kit inhibitor for the treatment of inflammatory diseases. Bioorganic & Medicinal Chemistry Letters. 18(14). 4137–4141. 6 indexed citations
6.
Kunz, Roxanne K., Dawei Zhang, Andrew S. Tasker, et al.. (2008). Discovery of amido-benzisoxazoles as potent c-Kit inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(18). 5115–5117. 10 indexed citations
7.
Hutzler, J. Matthew, et al.. (2005). Catalytic turnover of pyrene by CYP3A4: Evidence that cytochrome b5 directly induces positive cooperativity. Archives of Biochemistry and Biophysics. 438(1). 21–28. 32 indexed citations
8.
Ma, Bennett, Raju Subramanian, Michael Schrag, A. David Rodrigues, & Cuyue Tang. (2004). CYTOCHROME P450 2C8 (CYP2C8)-MEDIATED HYDROXYLATION OF AN ENDOTHELIN ETA RECEPTOR ANTAGONIST IN HUMAN LIVER MICROSOMES. Drug Metabolism and Disposition. 32(5). 473–478. 7 indexed citations
9.
Schrag, Michael, Donghui Cui, Thomas H. Rushmore, et al.. (2004). SULFOTRANSFERASE 1E1 IS A LOW KM ISOFORM MEDIATING THE 3-O-SULFATION OF ETHINYL ESTRADIOL. Drug Metabolism and Disposition. 32(11). 1299–1303. 45 indexed citations
10.
Cui, Donghui, Catherine Booth-Genthe, Edward J. Carlini, Brian Carr, & Michael Schrag. (2004). HETEROTROPIC MODULATION OF SULFOTRANSFERASE 2A1 ACTIVITY BY CELECOXIB: PRODUCT RATIO SWITCHING OF ETHYNYLESTRADIOL SULFATION. Drug Metabolism and Disposition. 32(11). 1260–1264. 4 indexed citations
11.
Lü, Ping, Michael Schrag, Donald E. Slaughter, et al.. (2003). MECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITOR. Drug Metabolism and Disposition. 31(11). 1352–1360. 86 indexed citations
12.
Ma, Bennett, Magang Shou, & Michael Schrag. (2003). SOLVENT EFFECT ON cDNA-EXPRESSED HUMAN SULFOTRANSFERASE (SULT) ACTIVITIES IN VITRO. Drug Metabolism and Disposition. 31(11). 1300–1305. 30 indexed citations
13.
Dabrowski, Michael J., Michael Schrag, Larry C. Wienkers, & William M. Atkins. (2002). Pyrene·Pyrene Complexes at the Active Site of Cytochrome P450 3A4:  Evidence for a Multiple Substrate Binding Site. Journal of the American Chemical Society. 124(40). 11866–11867. 75 indexed citations
14.
Schrag, Michael & Larry C. Wienkers. (2001). Covalent Alteration of the CYP3A4 Active Site: Evidence for Multiple Substrate Binding Domains. Archives of Biochemistry and Biophysics. 391(1). 49–55. 67 indexed citations
15.
Schrag, Michael & Larry C. Wienkers. (2001). Triazolam Substrate Inhibition. Advances in experimental medicine and biology. 29(1). 347–350. 55 indexed citations
16.
Schrag, Michael & Larry C. Wienkers. (2000). Topological Alteration of the CYP3A4 Active Site by the Divalent Cation Mg2+. Drug Metabolism and Disposition. 28(10). 1198–1201. 37 indexed citations
17.
Regal, Kelly, Michael Schrag, Ute M. Kent, Larry C. Wienkers, & Paul F. Hollenberg. (2000). Mechanism-Based Inactivation of Cytochrome P450 2B1 by 7-Ethynylcoumarin:  Verification of Apo-P450 Adduction by Electrospray Ion Trap Mass Spectrometry. Chemical Research in Toxicology. 13(4). 262–270. 33 indexed citations
18.
Schrag, Michael, et al.. (2000). A Refined 3-Dimensional QSAR of Cytochrome P450 2C9:  Computational Predictions of Drug Interactions. Journal of Medicinal Chemistry. 43(15). 2789–2796. 75 indexed citations
19.
Chatta, Gurkamal, et al.. (1993). Hematopoietic Progenitors and Aging: Alterations in Granulocytic Precursors and Responsiveness to Recombinant Human G-CSF, GM-CSF, and IL-3. Journal of Gerontology. 48(5). M207–M212. 96 indexed citations
20.
Schrag, Michael, et al.. (1988). Bacterial N-succinyl-L-diaminopimelic acid desuccinylase. Purification, partial characterization, and substrate specificity.. Journal of Biological Chemistry. 263(4). 1622–1627. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hsia-lien Lin Breakdown of academic impact, for papers by William R. Brian Breakdown of academic impact, for papers by Ken Grime Breakdown of academic impact, for papers by Hiroshi Komura Breakdown of academic impact, for papers by Tim F. Ryder Breakdown of academic impact, for papers by Jackie C. Bloomer Breakdown of academic impact, for papers by Xavier Boulenc Breakdown of academic impact, for papers by Susan Cole Breakdown of academic impact, for papers by David A. Tess Breakdown of academic impact, for papers by Hugues Dolgos
Rankless by CCL
2026